Wolny-Rokicka, E. I., & Grabowska, M. (2025). Ki67 and TNFRII as Potential Clinical Markers for Effective Clinical Staging of Advanced Prostate Cancer. Cancers, 17(16), 2638. https://doi.org/10.3390/cancers17162638
Chicago Style (17th ed.) CitationWolny-Rokicka, Edyta Idalia, and Marta Grabowska. "Ki67 and TNFRII as Potential Clinical Markers for Effective Clinical Staging of Advanced Prostate Cancer." Cancers 17, no. 16 (2025): 2638. https://doi.org/10.3390/cancers17162638.
MLA (9th ed.) CitationWolny-Rokicka, Edyta Idalia, and Marta Grabowska. "Ki67 and TNFRII as Potential Clinical Markers for Effective Clinical Staging of Advanced Prostate Cancer." Cancers, vol. 17, no. 16, 2025, p. 2638, https://doi.org/10.3390/cancers17162638.
Warning: These citations may not always be 100% accurate.